Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
about
Selective targeting of the stress chaperome as a therapeutic strategyRegulation and function of the human HSP90AA1 geneAurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP.Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP.Identification of novel putative-binding proteins for cellular prion protein and a specific interaction with the STIP1 homology and U-Box-containing protein 1.Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease.Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer.Oncogene and non-oncogene addiction in inflammation-associated cancers.The E3 ligase CHIP: insights into its structure and regulation.Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature.Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells.Hop/Sti1 phosphorylation inhibits its co-chaperone function.A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock responseMolecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants.Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibitionUBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells
P2860
Q28248791-46DF42F9-1413-4360-A2B5-8081EB96ABC3Q28646043-D87D4EBF-36A0-4CFE-83DC-AF16710951B8Q30252352-2ECBDFE6-03CA-4691-AC1D-909CFB5334B6Q33568348-D7D33C6B-25B9-452E-892E-49C1F6003EAFQ35551998-96815777-DC87-4293-8076-20B5F99AEDFEQ35735220-415CF523-E392-47E1-B080-9C25532472A7Q37198085-A7CC7751-B3CA-4055-833A-15244E0E028DQ37738855-ACBC917C-4D79-468B-9045-821D5D011253Q38096415-38041B39-F1CF-4450-A861-E7061DC038AFQ38215523-06AD9FF7-2F25-4ABA-B130-73B62D6D427FQ38459546-C851B43B-825C-4ED1-8C48-E7A6DC2FCF30Q38963334-8DA88105-B050-47CB-A97E-930288E577A0Q39010794-BB0C324E-C762-41D3-9A5C-DD3B17C9A39AQ39093264-1866142D-9375-4938-B103-52D34C1BCF25Q39823884-82B01023-7639-43F7-898A-E7B89430A5B2Q41854369-073CC03E-5714-4D50-A98D-BE1B4F6C4AAAQ41864092-68F3CB0A-53A4-4942-9396-C60D188E15BAQ45874458-2F9D0FA9-3477-4D4D-BB11-C83B0AE57830Q48171341-12C426FA-CB85-4EA7-B6C5-120D81BB3263Q52327617-152B3B3D-134F-4AAB-8C6B-F54E6B747814Q57167862-68DD8037-DD58-4D10-ACB7-E0D6519D3C65Q58766271-404604D1-9069-4826-BED6-74C3C0863973
P2860
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@en
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@nl
type
label
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@en
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@nl
prefLabel
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@en
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
@nl
P2093
P2860
P1476
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer
@en
P2093
Borivoj Vojtesek
Eva Ruckova
Rudolf Nenutil
P2860
P2888
P304
P356
10.2478/S11658-012-0021-8
P50
P577
2012-06-05T00:00:00Z
P6179
1040984356